A. Nickelsen

发表

Unexpected CK2 beta-antagonistic functionality of bisubstrate inhibitors targeting protein kinase CK2.

J. Jose, M. Pietsch, K. Niefind, 2020 .

Unexpected CK2β-antagonistic functionality of bisubstrate inhibitors targeting protein kinase CK2.

J. Jose, M. Pietsch, K. Niefind, 2020, Bioorganic chemistry.

De novo variants of CSNK2B cause a new intellectual disability-craniodigital syndrome by disrupting the canonical Wnt signaling pathway

Tzung-Chien Hsieh, N. Fleischer, P. Krawitz, 2022, HGG advances.

Structural and mechanistic basis of the inhibitory potency of selected 2-aminothiazole compounds on protein kinase CK2.

J. Jose, K. Niefind, D. Lindenblatt, 2020, Journal of medicinal chemistry.

Molecular Plasticity of Crystalline CK2α' Leads to KN2, a Bivalent Inhibitor of Protein Kinase CK2 with Extraordinary Selectivity.

C. Götz, J. Jose, K. Niefind, 2021, Journal of medicinal chemistry.

Diacritic Binding of an Indenoindole Inhibitor by CK2α Paralogs Explored by a Reliable Path to Atomic Resolution CK2α′ Structures

J. Jose, K. Niefind, D. Lindenblatt, 2019, ACS omega.

Analyzing the interactome of human CK2β in prostate carcinoma cells reveals HSP70‐1 and Rho guanin nucleotide exchange factor 12 as novel interaction partners

C. Götz, J. Jose, K. Niefind, 2023, FASEB bioAdvances.

Label-free flow cytometry-based enzyme inhibitor identification.

J. Jose, A. Nickelsen, 2021, Analytica chimica acta.

Structural and Enzymological Evidence for an Altered Substrate Specificity in Okur-Chung Neurodevelopmental Syndrome Mutant CK2αLys198Arg

J. Jose, K. Niefind, D. Lindenblatt, 2022, Frontiers in Molecular Biosciences.